EUDA Health Holdings Limited EUDA
17.86
1.44
8.77%
as of 25 Sep
- Market cap
- $49.2M
- P/E
- 0.0×
Follow EUDA
| Older periods | Jun '23 | Dec '23 | Jun '24 | Jun '25 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | — | — | — |
P/S ratio |
0.00 | — | — | — | |
P/FCF ratio |
0.00 | — | — | — | |
P/Operating CF |
(696.08) | — | — | — | |
P/B ratio |
0.00 | — | — | — | |
Price to Tangible BV |
0.00 | — | — | — | |
EV/Sales |
0.00 | — | — | — | |
EV/EBITDA |
0.00 | — | — | — | |
EV/Operating CF |
(133.19) | — | — | — | |
EV/FCF |
(133.19) | — | — | — | |
Quick Ratio |
0.15 | — | 0.08 | 0.12 | |
Current Ratio |
0.19 | — | 0.13 | 0.23 | |
Net Debt/EBITDA |
0.00 | — | 0.00 | 0.00 | |
Debt/Assets |
27.24% | 0.00% | 15.37% | 95.67% | |
Debt/Equity |
(0.09) | — | (0.05) | (0.54) | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.00 | — | 0.00 | 0.00 | |
Capex/Depreciation |
— | — | (0.15) | (0.26) | |
Research and Development Expense of Revenue |
1.50% | — | — | — | |
Selling, General and Administrative Expense of Revenue |
200.04% | — | — | — | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.17 | 0.12 | |
Share Based Compensation of Revenue |
0.00% | — | — | — | |
Graham Net Nets |
(0.02) | — | — | — | |
Graham Number |
4.15 | — | — | — | |
Earnings Yield |
(18.09%) | — | — | — | |
Free Cash Flow Yield |
(0.75%) | — | — | — | |
Revenue per Share |
0.05 | — | — | — | |
Operating CF per Share |
0.00 | — | 0.00 | 0.00 | |
Capex per Share |
0.00 | — | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | — | 0.00 | 0.00 | |
Cash per Share |
0.01 | — | 0.00 | 0.00 | |
Shareholders Equity per Share |
(0.28) | — | 0.00 | 0.00 | |
Interest Debt per Share |
0.00 | — | 0.00 | 0.00 | |
Book value per Share |
(0.28) | — | 0.00 | 0.00 | |
Free Cash Flow |
— | — | (1.26) | (1.24) | |
Working Capital |
(6.44) | — | (6.83) | (4.40) | |
Capital Expenditures |
— | — | 0.00 | (0.02) | |
Net Current Asset Value |
(6.58) | — | (6.98) | (4.54) | |
EV/EBIT |
0.00 | — | — | — | |
Capex to Sales |
0.00 | — | 0.00 | 0.00 | |
Net Profit Margin |
(550.96%) | — | — | — | |
Price to Operating Income |
0.00 | — | — | — | |
| Other line items | |||||
Average Receivables |
— | — | 2.15 | 1.31 | |
Average Payables |
— | — | 1.43 | 0.98 | |
Average Assets |
44.43 | 43.63 | 1.01 | 13.80 | |
Average Common Equity |
38.03 | — | 38.12 | (3.62) |
Columns are period end dates